Trial drug can significantly block early stages of COVID-19 in engineered human tissues

(University of British Columbia) An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news